Goldman Sachs’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$81.8M Buy
4,882,794
+917,537
+23% +$15.4M 0.01% 873
2025
Q1
$60.9M Buy
3,965,257
+448,418
+13% +$6.89M 0.01% 954
2024
Q4
$77.5M Sell
3,516,839
-641,489
-15% -$14.1M 0.01% 807
2024
Q3
$74.9M Sell
4,158,328
-132,319
-3% -$2.38M 0.01% 813
2024
Q2
$69.7M Buy
4,290,647
+746,787
+21% +$12.1M 0.01% 835
2024
Q1
$50M Sell
3,543,860
-261,488
-7% -$3.69M 0.01% 996
2023
Q4
$39.7M Sell
3,805,348
-633,945
-14% -$6.62M 0.01% 1118
2023
Q3
$45.3M Sell
4,439,293
-110,540
-2% -$1.13M 0.01% 975
2023
Q2
$34.3M Sell
4,549,833
-105,278
-2% -$793K 0.01% 1172
2023
Q1
$41.2M Sell
4,655,111
-683,033
-13% -$6.04M 0.01% 1033
2022
Q4
$48.7M Buy
5,338,144
+118,979
+2% +$1.09M 0.01% 994
2022
Q3
$42.1M Buy
5,219,165
+400,197
+8% +$3.23M 0.01% 1067
2022
Q2
$36.2M Buy
4,818,968
+1,425,393
+42% +$10.7M 0.01% 1173
2022
Q1
$31.9M Sell
3,393,575
-705,599
-17% -$6.63M 0.01% 1400
2021
Q4
$32.8M Buy
4,099,174
+837,955
+26% +$6.71M 0.01% 1400
2021
Q3
$31.8M Sell
3,261,219
-678,213
-17% -$6.61M 0.01% 1394
2021
Q2
$39M Sell
3,939,432
-216,456
-5% -$2.14M 0.01% 1255
2021
Q1
$48M Sell
4,155,888
-867,490
-17% -$10M 0.01% 1060
2020
Q4
$48.5M Buy
5,023,378
+484,420
+11% +$4.67M 0.01% 982
2020
Q3
$40.9M Buy
4,538,958
+1,391,151
+44% +$12.5M 0.01% 990
2020
Q2
$38.8M Buy
3,147,807
+58,920
+2% +$726K 0.01% 1038
2020
Q1
$27.7M Buy
3,088,887
+560,530
+22% +$5.03M 0.01% 1138
2019
Q4
$24.8M Sell
2,528,357
-292,434
-10% -$2.87M 0.01% 1478
2019
Q3
$19.4M Sell
2,820,791
-712,989
-20% -$4.91M 0.01% 1547
2019
Q2
$32.6M Buy
3,533,780
+954,670
+37% +$8.81M 0.01% 1282
2019
Q1
$40.4M Buy
2,579,110
+391,431
+18% +$6.14M 0.01% 1156
2018
Q4
$33.7M Buy
2,187,679
+228,622
+12% +$3.53M 0.01% 1203
2018
Q3
$42.2M Sell
1,959,057
-1,138,993
-37% -$24.5M 0.01% 1192
2018
Q2
$75.3M Sell
3,098,050
-1,768,329
-36% -$43M 0.02% 848
2018
Q1
$83.2M Buy
4,866,379
+1,377,896
+39% +$23.5M 0.02% 806
2017
Q4
$66.1M Buy
3,488,483
+2,238,537
+179% +$42.4M 0.02% 925
2017
Q3
$22M Sell
1,249,946
-848,254
-40% -$14.9M 0.01% 1525
2017
Q2
$69.7M Buy
2,098,200
+574,574
+38% +$19.1M 0.02% 864
2017
Q1
$48.9M Sell
1,523,626
-224,656
-13% -$7.21M 0.01% 1021
2016
Q4
$63.4M Sell
1,748,282
-615,650
-26% -$22.3M 0.02% 872
2016
Q3
$109M Sell
2,363,932
-938,374
-28% -$43.2M 0.03% 562
2016
Q2
$166M Sell
3,302,306
-778,110
-19% -$39.1M 0.05% 353
2016
Q1
$218M Sell
4,080,416
-919,546
-18% -$49.2M 0.07% 261
2015
Q4
$328M Buy
4,999,962
+2,865,756
+134% +$188M 0.1% 155
2015
Q3
$120M Buy
2,134,206
+578,098
+37% +$32.6M 0.04% 412
2015
Q2
$92M Buy
1,556,108
+4,339
+0.3% +$256K 0.03% 562
2015
Q1
$96.7M Sell
1,551,769
-427,038
-22% -$26.6M 0.03% 526
2014
Q4
$114M Buy
1,978,807
+507,477
+34% +$29.2M 0.04% 457
2014
Q3
$79.1M Buy
1,471,330
+257,623
+21% +$13.8M 0.03% 570
2014
Q2
$63.6M Sell
1,213,707
-557,154
-31% -$29.2M 0.02% 706
2014
Q1
$93.6M Sell
1,770,861
-2,161,746
-55% -$114M 0.03% 493
2013
Q4
$158M Buy
3,932,607
+481,604
+14% +$19.3M 0.05% 325
2013
Q3
$130M Buy
3,451,003
+67,125
+2% +$2.54M 0.05% 348
2013
Q2
$133M Buy
+3,383,878
New +$133M 0.05% 319